1-3 of 3
Marc Stewart, MD
Close
Sort by
Journal Articles

Reduced Intensity Allogeneic Transplantation Provides High Disease-Free and Overall Survival in Patients (Pts) with Advanced Indolent NHL and CLL: CALGB 109901.

Thomas C. Shea, MD, Jeffrey Johnston, MA, William Walsh, MD, Sherif Farag, MD, PhD, John McCarty, MD, Asad Bashey, MD, PhD, Luis Isola, MD, Marc Stewart, MD, Michael Kelly, MA, Kouros Owzar, PhD, Charles Linker, MD
Journal: Blood
Blood (2007) 110 (11): 486.
https://doi.org/10.1182/blood.V110.11.486.486
Published: 2007
Journal Articles

In Vivo Chemotherapy Protection and Efficacy of Multidrug Resistance (MDR-1) Gene Transfer in a Patient with Refractory Non-Hodgkin’s Lymphoma (NHL).

Pamela S. Becker, MD, PhD, Adrianne N. Hanks, BA, Ying Ping Yu, MD, Ann Marie Ceredona, MT(ASCP), MA, William V. Walsh, MD, Judith L. O’Donnell, BS, Christopher Baum, MD, Lynn Kallander, MT(ASCP), BS, Philip A. Lowry, MD, T.J. Fitzgerald, MD, Peter Westervelt, MD, PhD, F. Marc Stewart, MD
Journal: Blood
Blood (2005) 106 (11): 3054.
https://doi.org/10.1182/blood.V106.11.3054.3054
Published: 2005
Journal Articles

Transfer of the Multidrug Resistance Gene, MDR-1, to Hematopoietic Progenitors from a Patient with Transformed Large Cell Lymphoma, and Demonstration of In Vivo Chemotherapy Protection with Dose Escalating Chemotherapy.

Pamela S. Becker, MD, PhD, Ying Ping Yu, MD, Ann Marie Ceredona, MT, MA, William V. Walsh, MD, Judith L. O’Donnell, BS, RN, Christopher Baum, MD, Lynn Kallander, BS, Philip A. Lowry, MD, T. J. Fitzgerald, MD, Peter Westervelt, MD, PhD, F. Marc Stewart, MD
Journal: Blood
Blood (2004) 104 (11): 5278.
https://doi.org/10.1182/blood.V104.11.5278.5278
Published: 2004